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Graphene and graphene oxide induce ROS
production in human HaCaT skin keratinocytes:
the role of xanthine oxidase and NADH
dehydrogenase†
Marco Pelin, a,b Laura Fusco, a Cristina Martín, c,d Silvio Sosa, a
Javier Frontiñán-Rubio, d Jose Miguel González-Domínguez, d
Mario Durán-Prado, e Ester Vázquez, c,d Maurizio Prato *b,f,g and
Aurelia Tubaro *a
The extraordinary physicochemical properties of graphene-based nanomaterials (GBNs) make them
promising tools in nanotechnology and biomedicine. Considering the skin contact as one of the most
feasible exposure routes to GBNs, the mechanism of toxicity of two GBNs (few-layer-graphene, FLG, and
graphene oxide, GO) towards human HaCaT skin keratinocytes was investigated. Both materials induced a
signiﬁcant mitochondrial membrane depolarization: 72 h cell exposure to 100 μg mL−1 FLG or GO
increased mitochondrial depolarization by 44% and 56%, respectively, while the positive control valino-
mycin (0.1 µg mL−1) increased mitochondrial depolarization by 48%. Since the eﬀect was not prevented
by cyclosporine-A, it appears to be unrelated to mitochondrial transition pore opening. By contrast, it
seems to be mediated by reactive oxygen species (ROS) production: FLG and GO induced time- and con-
centration-dependent cellular ROS production, signiﬁcant already at the concentration of 0.4 µg mL−1
after 24 h exposure. Among a panel of speciﬁc inhibitors of the major ROS-producing enzymes, diphenyl-
iodonium, rotenone and allopurinol signiﬁcantly reverted or even abolished FLG- or GO-induced ROS
production. Intriguingly, the same inhibitors also signiﬁcantly reduced FLG- or GO-induced mitochondrial
depolarization and cytotoxicity. This study shows that FLG and GO induce a cytotoxic eﬀect due to a sus-
tained mitochondrial depolarization. This seems to be mediated by a signiﬁcant cellular ROS production,
caused by the activation of ﬂavoprotein-based oxidative enzymes, such as NADH dehydrogenase and
xanthine oxidase.
Introduction
Graphene is an allotrope of carbon consisting of a single atom
thick sheet of sp2-bonded carbons organized in a closely
packed honeycomb two-dimensional lattice ranging in the
nanosize dimension. This promising material, derived from
graphite,1–4 has been attracting increasing interest in recent
years, due to its unique electronic, mechanical and physico-
chemical properties.5–7
New kinds of two-dimensional graphene-based nano-
materials (GBNs), including the highly oxidized form of gra-
phene (graphene oxide, GO), have been produced to modify
and expand graphene properties. The potential applications of
GBNs range among various fields, including nanoelectronics,
energy technology and nanobiomedicine. However, safety
issues for human health need to be addressed, because the
GBNs market and the potential human exposure to these
materials are expected to significantly increase over the next
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years. In particular, the skin represents the body’s first line of
defense and can be considered one of the major exposure
routes to these materials during their production, use and dis-
charge, but little is known about their cutaneous toxicity.
Therefore, the potential dermatotoxicity of these novel
materials and the relevant mechanism(s) need to be
addressed. In this view, we recently demonstrated the ability of
a few layer graphene (FLG) and diﬀerent GOs to induce a sus-
tained cytotoxicity related to a reduced mitochondrial activity
in human skin HaCaT keratinocytes, a preliminary in vitro
model to investigate skin toxicity.8 It is widely known that one
of the main causes of mitochondrial dysfunction is rep-
resented by oxidative stress.9 Intriguingly, it has been
suggested that oxidative stress plays a major role in the cyto-
toxicity of other carbon-based nanomaterials.10 The link
between reactive oxygen species (ROS) overproduction and
mitochondrial damage is well known. Doubtlessly, mitochon-
dria are both the source and target of ROS, the latter being
able to induce an oxidative stress-caused mitochondrial
damage. Therefore, it is crucial to shed light on the role of
ROS in the mechanism of cytotoxicity induced by GBNs.
Herein, the mechanisms underlying GBN-induced mito-
chondrial damage in human HaCaT skin keratinocytes have
been investigated as one of the feasible intracellular pathways
of cytotoxicity consequent to nanomaterials exposure. For this
purpose, we selected two diﬀerent materials, representative of
GBNs, a research grade FLG and a commercially available gra-
phene oxide (GO), which were shown to induce a significant
oxidative damage at the mitochondrial level consequent to
NADH dehydrogenase- and xanthine oxidase-dependent ROS
production.
Experimental
Chemicals
Few layer graphene (FLG) was obtained by ball-milling, under
solvent-free conditions, as a powder easily dispersible in
culture media.11–13 The FLG sample was thoroughly character-
ized (ESI 1†): thermogravimetric analysis (TGA) was performed
with a TGA Q50 (TA Instruments, USA) at 10 °C per minute
under a nitrogen atmosphere, from 100 °C to 800 °C; Raman
spectra were studied using an InVia Raman microscope
(Renishaw plc, UK). At least 28 Raman measurements were col-
lected at 532 nm with a 100× objective and an incident power
of 1%. FLG was studied by high-resolution transmission elec-
tron microscopy (HRTEM) JEM 2100 (JEOL Ltd, JP), and the
lateral dimension distribution of the flakes was analyzed using
Fiji software. In addition, quantitative elemental analysis and
total reflection X-ray fluorescence (TXRF) of FLG were per-
formed using a LECO CHNS-932 analyzer and a Bruker-S2
PicoFox TXRF spectrometer, respectively. Graphene oxide (GO)
was received from Graphenea (San Sebastián, Spain), and was
characterized by average lateral dimensions of 979 nm, as
assessed by HRTEM and the O/C atomic ratio obtained from
XPS analysis equal to 0.51, as reported in our previous study.8
If not otherwise reported, all cell culture reagents were from
Euroclone (Milan, Italy).
Cell cultures
The human skin HaCaT cell line was purchased from Cell Line
Service (DKFZ, Eppelheim, Germany) and maintained in
DMEM high glucose with the addition of 10% fetal bovine
serum, 200 mM 1% L-glutamine, 10 000 IU mL−1 1% penicillin
and 10 mg mL−1 streptomycin. Cell cultures were maintained
according to standard procedures in a humidified incubator at
37 °C and with 5% CO2. For cytotoxicity experiments, the cells
were seeded at a density of 5 × 103 cells per well in 96-well
plates.
Cellular internalization of GBNs
Subcellular fractionation. HaCaT cells were plated into
6-well plates and incubated for 24 h with 5 μg mL−1 FLG. After
washing with Hanks’ solution, the cells were detached with
trypsin and plated again into 6-well plates for additional 24 h.
The cells were then scraped and lysed using 500 μL fraction-
ation buﬀer (250 mM sucrose, 20 mM Hepes, 10 mM KCl,
1.5 mM MgCl2, 1 mM ethylenediaminetetraacetic acid (EDTA),
1 mM glycoletherdiaminetetraacetic acid (EGTA), 1 mM dithio-
threitol, pH 7.4) supplemented with 1% protease inhibitor
cocktail (Roche; Germany). Lysate were passed 10 times
through a 25 gauge needle using 1 mL syringe and incubated
on ice for 20 minutes. Lysates were centrifuged at 720g for
5 minutes (4 °C), obtaining the nuclear and cytoplasm/mem-
brane fractions (pellet and supernatant, respectively).
Supernatants were centrifuged at 10 000g, obtaining the mito-
chondrial (MF) and cytoplasm/membrane (pellet and super-
natant, respectively) fractions. MF were washed by adding
500 μL of fractionation buﬀer, re-suspended, passed 10 times
through a 25 gauge needle and then centrifuged again at
10 000g for 10 minutes. The buﬀer was removed and mito-
chondrial pellets were re-suspended in the mitochondrial
buﬀer (SFB with 10% glycerol and 0.1% SDS added), sonicated
at 4 °C and deposited on a fragment of silicon wafer (Si-Mat
CZ) previously cleaned with isopropanol for Raman measure-
ments. As a negative control, to exclude the possible contami-
nation of GBNs between the subcellular fractions, FLG or GO
were added to untreated cells immediately before the fraction-
ation process.
Raman spectroscopy characterization. Raman spectra were
collected from the MF deposited onto a clean piece of silicon
wafer. A Renishaw InVia microspectrophotometer was used,
provided with a 532 nm point-based laser, and a 50× objective
(NA = 0.75). Measurements were taken with only 1% of the
maximum laser power, and 1 second of exposition time at
each pulse, in order to prevent damage to the sample caused
by laser overheating. The measuring routine consisted of track-
ing diﬀerent black spots (susceptible of being FLG) across the
sample, with the aid of the optical microscope (50× objective)
and obtaining their spectra in the range of 1300–2800 cm−1.
All spectra were baseline-corrected and smoothed, using
Renishaw Wire 4.4 and Origin 9.1 software tools, respectively.
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JC-1 mitochondrial membrane potential assay
Mitochondrial depolarization in HaCaT cells was evaluated
using a JC-1 Mitochondrial Staining Kit (Sigma-Aldrich; Milan,
Italy) following the manufacturer’s instructions. As a prelimi-
nary set of experiments, the potential interference of FLG or
GO with the assay was evaluated in an acellular system by incu-
bating each GBN (1–100 μg mL−1) with the JC-1 probe for
20 minutes at 37 °C. Subsequently, after cell exposure to GBNs
(1–100 μg mL−1) for increasing exposure times (24–72 h), the
medium was removed, the cells were washed three times with
PBS (200 μL per well) before adding 100 μL per well of 0.5 μM
JC-1 working solution for 20 minutes at 37 °C. As a positive
control, 0.1 μg mL−1 valinomycin was used. The cells were
then washed twice with ice-cold culture medium and the fluo-
rescence was immediately measured by using a Fluorocount
Microplate Fluorometer (Packard, Germany). Red fluorescence
given by JC-1 aggregates (intact mitochondria) was detected
with an excitation wavelength of 530 nm and an emission
wavelength of 590 nm whilst the green fluorescence was given
by JC-1 monomers (disrupted mitochondria) with a 485 nm
and 570 nm filter combination. The results are expressed as a
ratio between red and green fluorescence and are reported as
% relative to negative control (cells not exposed to GBNs).
Nitro blue tetrazolium (NBT) assay
ROS production by HaCaT cells exposed to GBNs was evaluated
by the NBT reduction assay, as previously reported.14,15 As a
preliminary set of experiments, the potential interference of
GBNs with the assay was evaluated in an acellular system by
incubating FLG or GO (0.4–100 μg mL−1) with the NBT reagent
for 4 h at 37 °C. Subsequently, the cells were exposed to FLG
or GO (0.4–100 μg mL−1) for 24 h. Then, the cells were washed
three times with PBS (200 μL per well) before adding fresh
medium (100 μL per well) containing NBT (final concen-
tration: 0.5 mg mL−1). After 4 h, the crystals were solubilized
by 140 μL DMSO and 120 μL KOH (2 M). The absorbance was
read by using an Automated Microplate Reader EL 311s (Bio-
Tek Instruments, Winooski, VT, USA) at 630 nm. The results
are expressed as % of ROS production as compared to negative
control (cells not exposed to GBNs).
Dichlorofluorescin diacetate (DCFDA) assay
ROS production by HaCaT cells exposed to GBNs was evaluated
by the 2′,7′-dichlorofluorescin diacetate (DCFDA) assay, as pre-
viously described.14 As a preliminary set of experiments, the
potential interference of GBNs with the assay was evaluated in
an acellular system by incubating FLG or GO (0.4–100 μg mL−1)
with the DCFDA probe for increasing time intervals up to
72 h at 37 °C. Subsequently, the cells were incubated with
medium (200 μL per well) containing DCFDA (final concen-
tration: 100 μM) for 30 min at 37 °C in the dark. The cells were
then washed twice with PBS containing Ca2+ and Mg2+
(200 μL per well) and exposed to GBNs (0.4–100 μg mL−1) in
complete medium without phenol red for increasing exposure
times (3–72 h). Fluorescence was read after increasing intervals
of time by using a Fluorocount Microplate Fluorometer
(Packard, Germany) with an excitation wavelength of 485 nm
and an emission wavelength of 570 nm. The results are
expressed as % of ROS production as compared to negative
control (cells not exposed to GBNs). The cells exposed to each
concentration of FLG or GO without any probe were used to
assess any absorbance properties of the tested GBNs and the
relevant data were considered as blanks.
Luminol assay
ROS production by HaCaT cells exposed to GBNs was also eval-
uated by the luminol assay. Preliminarily, the potential inter-
ference of FLG and GO with the assay was evaluated in an
acellular system by incubating each GBN (0.4–100 μg mL−1)
with luminol for 15 minutes at 37 °C. Subsequently, the cells
were seeded overnight at a density of 1 × 104 cells per well in
96-well white plates and exposed to GBNs (0.4–100 μg mL−1)
for 24 h before adding luminol (1 μM) to each well.
Chemiluminescence was recorded 15 minutes after luminol
addition, by using a multiwell luminometer (Wallac 1450
Microbeta counter, PerkinElmer, Milan, Italy). The results are
expressed as % of ROS production as compared to negative
control (cells not exposed to GBNs).
CCK-8 assay
The eﬀect of GBNs on HaCaT cell viability was evaluated by
the Cell Counting Kit (CCK)-8 assay (Sigma Aldrich; Milan,
Italy) following the manufacturer’s instructions. After exposure
to FLG or GO (1–100 μg mL−1), the cells were washed three
times with PBS (200 μL per well) and incubated for 4 h with
fresh medium (100 μL per well) containing 10 μL of the probe.
Absorbance was subsequently read at 450 nm by using an
Automated Microplate Reader EL 311s (Bio-Tek Instruments,
Winooski, VT, USA). Data are reported as % of cell viability as
compared to negative control (cells not exposed to GBNs).
Statistical analysis
The results are presented as mean ± SE from at least three
independent experiments performed in triplicate. Statistical
analysis was performed by a two-way ANOVA followed by
Bonferroni’s post-test (GraphPad Prism version 6.00) and stat-
istical significance was considered for p < 0.05.
Results
Characterization of FLG
The FLG sample was thoroughly characterized using diﬀerent
techniques such as Raman spectroscopy, TGA, HRTEM,
elemental analysis and TXRF (Fig. 1).
The Raman spectrum shows the two most intense bands of
graphene, the G peak at around 1580 cm−1 and the 2D band at
around 2700 cm−1. The intensity ratio I(2D)/I(G) falls below 1,
as described for few layer graphene.16 In fact, only 3 layers
were calculated for our FLG.17 The disorder-induced D band,
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appears at 1345 cm−1, being the intensity ratio I(D)/I(G) of 0.4,
which reveals a low density of defects. Elemental analysis
shows average values of 95.7 ± 0.51% C, 0.42 ± 0.042% H,
0.43 ± 0.014% N and 0.22 ± 0% S. The oxygen content, less
than 3.5%, is compatible with the weight loss at 600 °C
observed by TGA. These results corroborate the low number of
defects presented in the FLG sheets. HRTEM analysis was
used to determine the lateral dimensions of FLG from at least
100 diﬀerent sheets. A lateral size distribution between 200
and 1200 nm was obtained with an average lateral dimension
of 391 ± 238 nm and a major population <1 µm, significantly
lower than that of GO (average lateral dimension of 979 nm).8
Finally, since a stainless-steel flask is used during the ball-
milling process, TXRF was performed to ensure the absence of
metals, especially Fe, in the FLG sample, revealing a Fe
concentration of only 0.026 mg L−1 (ESI 1†).
Internalization of GBNs in HaCaT cells
To investigate if GBNs can be internalized into HaCaT kerati-
nocytes, the cells were fractionated into nuclear, mitochon-
drial, cytoplasm and membrane fractions after 24 h exposure
to the materials and their presence in each fraction was
assessed by Raman spectroscopy. Both FLG and GO were
detected in all the fractions, suggesting that they can be inter-
nalized into HaCaT cells (data not shown). As a representative
of GBNs, herein only the results related to FLG are presented.
Fig. 2 shows the typical morphology of FLG in the mitochon-
drial fraction (MF), as shown by the black spot represented in
the micrograph (panel A). In addition, FLG Raman fingerprints
were detected in around 50% of all the aforesaid black spots,
contained in MF, demonstrating that FLG is interacting with
mitochondria (panel B). This result indicates the presence of
FLG in HaCaT MF. It is also interesting to note that the cellular
environment also has its own Raman bands, which are visible
in the FLG profile, possibly explaining the somewhat higher
D-Band as compared to the starting FLG. In contrast, in the
negative control, only the profile corresponding to the MF was
found, but not the FLG characteristic spectrum.
These data cannot demonstrate if FLG is inside the mito-
chondria or attached to their outer membrane. However,
together with FLG detection in the membrane, cytosol and
nuclei, they unequivocally show that FLG is internalized into
HaCaT cells.
FLG and GO induce mitochondrial membrane depolarization,
not dependent on mitochondrial permeability transition pore
opening
The mitochondrial eﬀects of FLG and GO on HaCaT cells were
evaluated by means of mitochondrial depolarization (JC-1 fluo-
rescence shift) after diﬀerent exposure times, up to 72 h. As
Fig. 1 Chemical characterization of FLG by Raman spectroscopy as an average of 28 spectra (A), thermogravimetric analysis (B), representative
HRTEM image (C) and lateral size distribution (n = 107) of FLG (D).
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reported in Fig. 3, both FLG and GO (1–100 μg mL−1) induced
a concentration-dependent mitochondrial membrane depolar-
ization already after 24 h exposure (29 and 31% at 100 µg mL−1
for FLG and GO, respectively). The eﬀect was also time-depen-
dent and, after 72 h exposure, the highest concentration
(100 µg mL−1) of FLG or GO induced 48% (p < 0.001) or 57%
(p < 0.001) mitochondrial depolarization, respectively.
As a positive control, valinomycin (0.1 µg mL−1) induced 48%
(p < 0.001) mitochondrial depolarization.
To investigate the mechanism of mitochondrial depolariz-
ation induced by FLG and GO, their eﬀects were evaluated in
the presence of cyclosporine A (Cs A), a well-known inhibitor
of mitochondrial permeability transition pore (MPTP) for-
mation. HaCaT cells were pre-exposed to Cs A (0.2 µg mL−1)
for 1 h and subsequently to FLG or GO (1–100 μg mL−1) and
Cs A up to 72 h. As shown in Fig. 4, the eﬀects of FLG and GO
on mitochondrial depolarization after 72 h exposure were not
reverted by Cs A (p > 0.05), suggesting that FLG- and GO-
increased mitochondrial depolarization is not mediated by
MPTP formation. Similar results were obtained after 24 and
48 h exposure (ESI 2†).
Fig. 2 (A) Optical microscopy image of mitochondrial fraction (MF) de-
posited on silicon oxide, showing typical morphologies (centre of the
image) which correspond to FLG, according to their Raman spectrum.
Scale bar = 20 µm. (B) Raman spectra of FLG alone, MF alone, FLG
found in MF and MF negative control. The FLG spectrum is an average of
more than 20 spectra, whereas the other spectra are an average of 5
repetitions. Every spectrum is normalized to its own highest-intensity
band.
Fig. 3 Mitochondrial depolarization in HaCaT cells exposed to FLG or GO (1–100 μg mL−1) for 24 (A), 48 (B) and 72 h (C). As a positive control, the
cells were exposed to valinomycin (0.1 µg mL−1). Results are presented as % of JC-1 ﬂuorescence shift with respect to negative control (cells not
exposed to GBNs) calculated on the ratio between red (530/590 nm) and green (485/570 nm) ﬂuorescence. Data are the mean ± SE of 3 indepen-
dent experiments performed in triplicate. Statistical diﬀerences vs. untreated control: *p < 0.05; ***p < 0.001 (two-way ANOVA and Bonferroni’s
post-test).
Fig. 4 Role of MPTP opening in the mitochondrial depolarization in
HaCaT cells exposed to FLG (A) or GO (B). HaCaT cells were pre-
exposed to 0.2 μg mL−1 Cs A for 1 h and then exposed to GBNs and Cs A
for 72 h. Mitochondrial membrane depolarization induced by FLG or GO
in the presence of Cs A is compared to that induced by FLG or GO
alone. Results are presented as % of ﬂuorescence shift with respect to
the negative control (cells not exposed to GBNs). Results are the mean ±
SE of 3 independent experiments performed in triplicate. No statistical
diﬀerences were observed between the cells exposed to GBNs with or
without Cs A (two-way ANOVA and Bonferroni’s post-test).
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FLG and GO induce a concentration- and time-dependent
reactive oxygen species production
To verify whether mitochondrial membrane depolarization is
mediated by reactive oxygen species (ROS) overproduction,
FLG and GO were evaluated for their ability to increase ROS
levels in HaCaT keratinocytes after 24 h exposure. The amount
of specific ROS was evaluated by three methods: NBT
reduction assay, luminol assay and DCFDA fluorescence assay,
able to specifically measure superoxide anion, hydrogen per-
oxide and peroxynitrite/hydroxyl radicals, respectively. As
shown in Fig. 5, FLG induced a significant concentration-
dependent increase of ROS production starting from the con-
centration of 33 μg mL−1 (DCFDA and NBT assay, p < 0.05) or
above 1 μg mL−1 (luminol assay, p < 0.05). GO significantly
increased ROS production at the concentration of 33 μg mL−1
and above, recorded by all the assays (p < 0.05). At the highest
concentration tested (100 μg mL−1), FLG increased ROS pro-
duction by 9% (NBT assay, p < 0.01), 39% (luminol assay, p <
0.001) and 25% (DCFDA assay, p < 0.01). GO (100 μg mL−1)
increased ROS production by 36% (p < 0.01), 21% (p < 0.01) and
39% (p < 0.001), as assessed by the NBT, luminol and DCFDA
assays, respectively. Only at this concentration, GO was signifi-
cantly more active than FLG in increasing ROS production as
assessed by NBT (p < 0.01). The positive control 2,2′-azobis(2-ami-
dinopropane)dihydrochloride (AAPH, 0.3 mg mL−1) increased
ROS production by 32% (p < 0.001), 91% (p < 0.001) and 148%
(p < 0.001), as assessed by the NBT, luminol and DCFDA assays,
respectively. Preliminary experiments carried out in acellular
systems revealed no ROS production detectable by each assay at
all GBNs concentrations. Only a significant reduction of the
signal was observed by the DCFDA assay at the highest FLG con-
centrations (33–100 μg mL−1), as reported below.
To deeply investigate the eﬀects of GBNs, the kinetics of
ROS production by HaCaT cells exposed to FLG or GO
(0.4–100 μg mL−1) was investigated after increasing intervals of
time (3 to 72 h exposure), using a time-dependent DCFDA assay.
As shown in Fig. 6, FLG- and GO-induced ROS production was
time-dependent at all the concentrations tested. In particular, as
compared to the negative control cells not exposed to GBNs, the
incubation of HaCaT cells with GO significantly increased ROS
production already after 12 h (p < 0.05, 100 μg mL−1), while FLG
induced a significant ROS production starting from 24 h exposure
(p < 0.05, at 0.4 μg mL−1 and above). Cell exposure to the highest
concentration (100 μg mL−1) of FLG or GO for 72 h increased ROS
production by 85% or 124%, respectively (p < 0.001). These
eﬀects were lower than that induced by the positive control AAPH
(0.3 mg mL−1), which increased ROS production by 304% after
72 h exposure (p < 0.001). On the whole, ROS production induced
by GO was significantly higher than that induced by FLG,
starting from the concentration of 33 μg mL−1 after 48 h exposure
(p < 0.05).
ROS production in HaCaT cells exposed to FLG or GO was
not dependent on the spontaneous ability of GBNs to generate
free radicals, since neither FLG nor GO induced ROS pro-
duction in cell-free culture medium up to 72 h. In contrast,
only a significant signal reduction was observed for FLG at the
concentration of 33 μg mL−1 and above (ESI 3†).
FLG- and GO-induced ROS production is mediated by the
activation of NADH dehydrogenase and xanthine oxidase
The putative role of specific HaCaT cell ROS-generating
enzymes in FLG- and GO-induced ROS production was investi-
gated using selective inhibitors of these enzymes. In particu-
lar, HaCaT cells were pre-exposed for 1 h to diphenyliodonium
chloride (DPI; 1 µg mL−1), an inhibitor of flavoprotein
enzymes, apocynin (1 µg mL−1), a selective inhibitor of NADPH
oxidase (NOX), L-NG-monomethyl arginine citrate (L-NMMA;
75 µg mL−1), a selective inhibitor of nitric oxide synthase
(NOS), rotenone (2 µg mL−1), a selective inhibitor of mito-
Fig. 5 Reactive oxygen species (ROS) production in HaCaT cells
exposed to FLG (A) or GO (B) for 24 h, evaluated by NBT reduction assay,
DCFDA ﬂuorescence and luminol assay. As positive control, the cells
were exposed to AAPH (0.3 mg mL−1). Data are expressed as % of ROS
increase in comparison to negative control (cells not exposed to GBNs)
and are the mean ± SE of at least 3 independent experiments performed
in triplicate. Statistical diﬀerences: *p < 0.05; **p < 0.01; ***p < 0.001
(two-way ANOVA and Bonferroni’s post-test).
Fig. 6 Kinetics of ROS production in HaCaT cells exposed to FLG (A) or
GO (B) up to 72 h, evaluated by the DCFDA assay. Results are expressed
as % of ROS increase with respect to negative control (cells not exposed
to GBNs) and are the mean ± SE of at least 3 independent experiments
performed in triplicate. As positive control, the cells were exposed to
AAPH (0.3 mg mL−1). Statistical diﬀerences: *p < 0.05; **p < 0.01; ***p <
0.001 (two-way ANOVA and Bonferroni’s post-test).
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chondrial complex I (NADH dehydrogenase), indomethacin
(35 µg mL−1), an inhibitor of cyclooxygenases (COXs), or
allopurinol (10 µg mL−1), an inhibitor of xanthine oxidase
(XO). Subsequently, the cells were exposed to FLG or GO
(1–100 μg mL−1) and the same specific inhibitors for 72 h, and
ROS production was measured by the DCFDA assay. The
eﬀects were evaluated as % increase in ROS production with
respect to the negative control (cells exposed to each selected
inhibitor, without GBNs). As shown in Fig. 7 (panels A and B),
the inhibitor of flavoprotein-based enzymes DPI, the inhibitor
of NADH dehydrogenase, rotenone, and the inhibitor of
xanthine oxidase, allopurinol, significantly reduced or even
abolished ROS production induced by FLG or GO at
10 μg mL−1 and above. In particular, DPI, rotenone and allo-
purinol reduced ROS overproduction induced by the highest
FLG concentration (100 μg mL−1) by 53% (p < 0.001), 95%
(p < 0.001) and 96% (p < 0.001), respectively. ROS overproduc-
tion induced by GO (100 μg mL−1) was reduced by DPI,
rotenone and allopurinol by 57% (p < 0.001), 75% (p < 0.001)
and 81% (p < 0.001), respectively. The other inhibitors did not
significantly aﬀect FLG- or GO-induced ROS production.
FLG- and GO-induced mitochondrial damage is mediated by
the activation of NADH dehydrogenase and xanthine oxidase
To investigate the relationship between FLG- or GO-induced
oxidative stress and FLG- or GO-induced mitochondrial
damage in HaCaT cells, the changes in mitochondrial mem-
brane potential were evaluated by the JC-1 assay, in the pres-
Fig. 7 Eﬀect of selected inhibitors of ROS-generating enzymes on FLG- and GO-induced ROS production, mitochondrial depolarization and cyto-
toxicity in HaCaT cells. The cells were pre-exposed to 5.0 × 10−6 M DPI, 1.0 × 10−5 M apocynin, 1.0 × 10−4 M L-NMMA, 5.0 × 10−6 M rotenone, 1.0 ×
10−4 M indomethacin or 1.0 × 10−4 M allopurinol for 1 h and subsequently exposed to FLG or GO and the same selected ROS-generating enzyme
inhibitor for 72 h. ROS production was measured by DCFDA assay (panels A and B), mitochondrial depolarization by JC-1 ﬂuorescence shift (panels
C and D) and cell viability by CCK-8 assay (panels E and F). Data are expressed as % diﬀerence of each measured parameter with respect to relevant
negative control (cells exposed to each selected inhibitor, without GBNs) and are the mean ± SE of 4 independent experiments performed in tripli-
cate. Statistical diﬀerences: *p < 0.05; **p < 0.01; ***p < 0.001 (two-way ANOVA and Bonferroni’s post-test).
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ence of the ROS-producing enzyme inhibitors used in the pre-
vious set of experiments. The cells were pre-exposed to each
inhibitor for 1 h and subsequently exposed to FLG or GO
(1–100 μg mL−1) and the same inhibitor for 72 h. The eﬀects
were evaluated as % increase in mitochondrial depolarization
with respect to the negative control (cells exposed to each
selected inhibitor, without GBNs). As observed for the ROS
production by the DCFDA assay (Fig. 7, panels A and B), DPI,
rotenone and allopurinol also significantly reduced the mito-
chondrial depolarization induced by FLG or GO at 10 μg mL−1
and above (Fig. 7, panels C and D). In particular, mitochon-
drial depolarization evoked by the highest FLG concentration
(100 μg mL−1) was reduced by DPI, rotenone and allopurinol
by 56% (p < 0.001), 79% (p < 0.001) and 96% (p < 0.001),
respectively. Similarly, DPI, rotenone and allopurinol reduced
mitochondrial depolarization induced by 100 μg mL−1 GO by
59% (p < 0.001), 73% (p < 0.001) and 87% (p < 0.001), respect-
ively. In contrast, the other inhibitors did not aﬀect FLG- or
GO-induced mitochondrial depolarization.
FLG- and GO cytotoxicity is mediated by the activation of
NADH dehydrogenase and xanthine oxidase
To investigate the relationship between FLG- or GO-induced
oxidative stress and their cytotoxicity, HaCaT cells were pre-
exposed for 1 h to the ROS-producing enzyme inhibitors used
in the previous set of experiments, and subsequently exposed
to FLG or GO (1–100 μg mL−1) and the same selective inhibi-
tors for 72 h. Cell viability was then evaluated by the CCK-8
assay. The eﬀects were evaluated as % diﬀerence of cell viabi-
lity as compared to the negative control (cells exposed to each
selected inhibitor, without GBNs). As shown in Fig. 7 (panels
E and F), FLG and GO induced a concentration-dependent
decrease of viable cells, with GO being significantly more cyto-
toxic than FLG at the highest concentrations (10 and 100
μg mL−1; p < 0.01). This cytotoxic eﬀect was significantly
counteracted by DPI, rotenone and allopurinol in cells exposed
to FLG or GO at 10 μg mL−1 and above. In particular, as com-
pared to the negative control, exposure to the highest FLG con-
centration (100 μg mL−1) reduced viable cells to 36%, whereas
viable cells after FLG and DPI, rotenone or allopurinol co-
exposure were significantly increased up to 84% (p < 0.001),
95% (p < 0.001) and 99% (p < 0.001), respectively. Similarly,
cell exposure to 100 μg mL−1 GO reduced cell viability to 14%
while their co-exposure with GO and DPI, rotenone or allopuri-
nol counteracted the GBN eﬀect, significantly increasing
cell viability up to 80% (p < 0.001), 60% (p < 0.001) or 100%
(p < 0.001), respectively. In contrast, the other inhibitors did
not counteract FLG- or GO-induced cytotoxicity.
Discussion
In recent years, GBNs have attracted attention for their promis-
ing applications in biomedical and optoelectronic fields.
However, despite the occupational cutaneous exposure and
their potential skin applications, mainly as wound healing
applications and skin sensors as well as artificial and elec-
tronic skin,18,19 data on their cutaneous toxicity are still
limited. Indeed, skin biocompatibility of GBNs is largely un-
explored, although other carbon-based nanomaterials, such as
carbon nanotubes, may lead to adverse skin reactions of
diﬀerent severities.20,21 Recently, we provided the first com-
parative study of the eﬀects of diﬀerent GBNs on human
HaCaT keratinocytes, a widely used in vitro model to predict
skin toxicity. On this in vitro skin model, GBNs exerted a sig-
nificant cytotoxicity, with variable potencies depending on
their oxidation state.8 Considering that mitochondrial damage
is a common feature of the mechanism of toxicity of carbon-
based nanomaterials,22,23 the present study was aimed to
investigate the putative mechanism(s) of mitochondrial
damage induced by a research grade FLG and a commercially
available GO on skin keratinocytes.
In HaCaT cells exposed to these materials, both FLG and
GO were detected in cell membranes, cytosol, mitochondria
and nucleus, as observed by Raman spectroscopy. FLG and GO
induced a concentration-dependent mitochondrial membrane
depolarization already after 24 h. Prolonging the exposure to
72 h, the eﬀect also appeared to be time-dependent. These
data suggest that FLG and GO can induce a significant mito-
chondrial depolarization, as a possible cause of mitochondrial
damage. These results are supported by previous studies
reporting the ability of other GBNs to induce mitochondrial
depolarization, such as carboxyl graphene,24 pristine gra-
phene25 and few layer graphene (obtained by the arc discharge
method).26 To evaluate the involvement of MPTP opening as a
causative mechanism of FLG- and GO-induced mitochondrial
depolarization, a set of experiments was carried out co-expos-
ing HaCaT cells with Cs A, a well-known inhibitor of MPTP
opening.27 However, in our model, MPTP opening does not
seem to be involved in the mitochondrial damage, since Cs A
was unable to prevent FLG- and GO-induced mitochondrial
depolarization at any concentration and exposure time to
GBNs.
It is well known that one of the main causes of mitochon-
drial damage is the increased ROS cellular levels.9 Hence, in
the eﬀort to investigate an alternative putative mechanism of
mitochondrial depolarization, the role of ROS was evaluated.
Both FLG and GO induced a concentration-dependent increase
of ROS production in HaCaT skin keratinocytes after 24 h
exposure. For the first time, this eﬀect was assessed by three
diﬀerent ROS detection methods: spectrophotometric (NBT),
chemiluminescent (luminol) and fluorometric (DCFDA).
To deeply investigate the role of ROS in the mechanism of
mitochondrial dysfunction, the kinetics of their production
was evaluated using the DCFDA assay, the most suitable
method to perform a time course measurement. FLG and GO
induced a significant time-dependent ROS production already
after 24 and 12 h exposure, respectively, an eﬀect significantly
lower than that of the positive control AAPH, a free radical
initiator. However, an underestimation of the eﬀect of GBNs
due to their ability to quench the dye fluorescence cannot be
excluded. In fact, in line with the literature data on the
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quenching properties of GBNs,28 FLG significantly reduced the
DCFDA signal under cell-free conditions, starting from the
concentration of 33 µg mL−1 (ESI 3†), which suggests a poss-
ible underestimation of cellular ROS production induced by
GBNs, at least at the highest concentrations. In contrast, no
interference between FLG or GO and NBT or luminol was
observed, suggesting the absence of possible false positive or
negative results. In addition, possible particle overload,
especially at the highest concentration, should be considered
as an additional factor that might influence the eﬀects of
GBNs. Notwithstanding, a significant ROS production was
observed also at concentrations as low as 0.4 µg mL−1, at
which particle overload cannot be expected.
Intriguingly, 12–72 h exposure to GO induced a ROS pro-
duction higher than that induced by FLG, with a significant
diﬀerence starting from 48 h exposure. This result is in agree-
ment with the finding that the higher density of oxygen-con-
taining functional groups on the GO surface in comparison to
FLG can enhance the production of ROS.29 Altogether, these
observations are in line with previous results, supporting the
oxidation state of GBNs as an important feature for their cyto-
toxic potency,8,30 even though other physicochemical pro-
perties (i.e. dimension, aggregation, shape, etc.) could aﬀect
their cytotoxicity.
These results are in agreement with previous studies report-
ing ROS overproduction induced by FLG (obtained with
diﬀerent methodologies) in PC12 cells31 and Human
Umbilical Vein Endothelial Cells (HUVEC) after 24 h
exposure,26 and by other GO (Hummers’ method) after 24 h
exposure in A549 cells,32 MCF7 cells,33 HeLa cells,34
MDA-MB-231 cells35 and BEAS-2B cells.36 Furthermore, Li and
coworkers (2012) have shown that commercial pristine gra-
phene can induce ROS production and depletion of the mito-
chondrial membrane potential in murine RAW 264.7 macro-
phages after 24 h exposure, triggering apoptosis by activation
of the mitochondrial pathway.25 In immune cells (Jurkat T lym-
phocytes and THP-1 monocytes), the mitochondrial pathway
seemed to be aﬀected by a GO prepared using a modified
Hummers’ method, by altering the oxidative phosphoryl-
ation.37 Similarly, GO seems to induce mitochondrial altera-
tions by increasing the activity of mitochondrial electron trans-
port complexes in MHS cells.38 It has been reported that oxi-
dative stress may also be indirectly derived by a decreased
activity of antioxidant enzymes, such as superoxide dismutase
and glutathione peroxidase, as reported for GO.22,36 However,
no information on the molecular mechanism of ROS gene-
ration induced by GBNs is available, so far. Hence, the putative
molecular mechanism(s) of cellular ROS production induced
by GBNs was investigated. With this aim, six well-known
inhibitors of the major ROS-generating enzymes expressed in
HaCaT cells were evaluated for their ability to reduce GBNs-
induced oxidative stress. Only DPI, rotenone and allopurinol
significantly reduced or even abolished GBNs-increased ROS
levels. The eﬀects of rotenone and allopurinol suggest a role
for mitochondrial electron transport chain complex I (NADH
dehydrogenase) and xanthine oxidase in GBNs-induced ROS
production. This observation is further supported by the
ability of DPI to inactivate flavoprotein-based enzymes, such as
mitochondrial NADH dehydrogenase and xanthine
oxidase.39,40 Intriguingly, the same inhibitors also significantly
reduced or even abolished GBNs-induced mitochondrial
depolarization and cytotoxicity. These data suggest that ROS
production, mediated by mitochondrial NADH dehydrogenase
and xanthine oxidase, might also be involved in the mecha-
nism of mitochondrial damage induced by GBNs leading to
reduced cell viability. Altogether, for the first time, these
results identify a possible intracellular pathway of ROS-depen-
dent mitochondrial damage evoked by GBNs, which involves
the activation of flavoprotein-based enzymes. However, even
though GBNs can interact with the plasma membrane to reach
the cytoplasm, mitochondria and nucleus of HaCaT cells, their
ability to directly activate these enzymes cannot be excluded.
Tentatively, the mitochondrial dysfunction driven by their acti-
vation could be hypothesized as a secondary stress response to
the insult given by GBNs entrance inside the cells or by their
perturbation of cell membrane, as previously observed.8 In
fact, xanthine oxidase is reported to be located not only in the
cytoplasm, but also on the plasma membrane.41–43 In
addition, we cannot exclude the involvement of other mecha-
nism(s) in the mitochondrial damage induced by GBNs,
including a disruption of osmotic balance consequent to
plasma membrane damage.8 Similarly, other cellular struc-
tures and pathways that could be involved in FLG- and GO-
induced cytotoxicity cannot be excluded.
On the whole, these results should be taken into account
when considering GBNs for possible biomedical applications
at the skin level, e.g. for wound healing.44 Indeed, the sus-
tained ROS production and the consequent mitochondrial
depolarization might hinder the use of GBNs in such appli-
cations. In addition, it is well known that ROS production is a
key element in triggering and modulating inflammation.
Moreover, activated keratinocytes may interact with inflamma-
tory/immunity cells, such as monocytes, macrophages and/or
resident dendritic cells (i.e. Langerhans cells). In this scenario,
the eﬀects of GBNs on some of these cells have already been
investigated.45 Indeed, GBNs were shown to upregulate critical
genes implicated in immune responses and induce the release
of pro-inflammatory cytokines from healthy donors’ immune
cells.46 FLG was also shown to exert a selective killer action
towards monocytes.47,48 Similarly, pro-inflammatory eﬀects of
GBNs were also observed on macrophages, with GO being able
to activate the inflammasome49 and enhance the production
of inflammatory cytokines50 in a size-dependent manner.
Altogether, these observations support the hypothesis of pro-
inflammatory properties of GBNs at the cutaneous level. Thus,
further studies are needed to assess the safety of the bio-
medical applications of GBNs at the skin level.
It is noteworthy that the oxidative enzymatic machinery
generating ROS is required for the eﬀective degradation of car-
bonaceous nanomaterials. For instance, it is reported that
xanthine oxidase can oxidize multi-walled carbon nanotubes
(MWCNTs).51 Similarly, the superoxide/nitric oxide/peroxy-
Paper Nanoscale
11828 | Nanoscale, 2018, 10, 11820–11830 This journal is © The Royal Society of Chemistry 2018
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
1 
Ju
ne
 2
01
8.
 D
ow
nl
oa
de
d 
on
 7
/5
/2
01
8 
2:
45
:1
4 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
nitrite-driven pathway, mainly catalyzed by inducible nitric
oxide synthase (iNOS) and NADPH oxidase, seems to be
involved in the oxidative biodegradation of single-walled
carbon nanotubes (SWCNTs).52 However, these biodegradation
pathways have been characterized only in immune and inflam-
matory cells, so far. To the best of our knowledge, no data are
available on the possible interaction of GBNs with these
enzymes in non-immune/inflammatory cells, such as skin
keratinocytes, which are the first line of body defense. In this
view, the biodegradation pathways of GBNs in skin keratino-
cytes might involve flavoprotein-based oxidative enzymes, such
as xanthine oxidase, triggering oxidative stress conditions and
the consequent mitochondrial damage (Fig. 8).
Conclusions
In conclusion, the results of this study may represent a signifi-
cant step forward in the hazard identification and mechanism
of toxicity of GBNs. In particular, FLG and GO are able to inter-
nalize inside HaCaT cells, inducing a significant intracellular
ROS production, which in turn induces a sustained mitochon-
drial depolarization not mediated by MPTP opening. ROS pro-
duction seems to be mediated mainly by the activation of fla-
voprotein-based oxidative enzymes, such as NADH dehydro-
genase and xanthine oxidase, known to be present at the mito-
chondrial and cytosolic/cell membrane level, respectively. The
selective activation of these intracellular enzymes suggests that
GBNs-induced mitochondrial dysfunction is not consequent to
a direct mitochondrial eﬀect, but a secondary cellular response
induced by the interaction of GBNs with HaCaT skin
keratinocytes.
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